Form 4: Organon Executive Nisita Reports Share Acquisitions
Insider Transaction Report
Organon & Co.'s Head of Global Business Services, Vittorio Nisita, reported the acquisition of common stock through performance share unit vesting and dividend equivalents, alongside related tax withholdings.
Summary
- Vittorio Nisita, Head of Global Business Services at Organon & Co., reported changes in beneficial ownership of common stock.
- On February 27, 2026, Nisita acquired 16,287 shares of Organon & Co. common stock at a price of $0, stemming from the release of performance share units (PSUs) granted on August 11, 2023, after performance goal attainment was certified by the Talent Committee of Organon's Board of Directors.
- On the same date, 6,210 shares were disposed of at $7.17 per share, likely to cover tax withholding obligations related to the PSU vesting.
- Additionally, 4,596 shares of common stock were acquired at $0, representing dividend equivalents earned on the released PSUs.
- A further 1,575 shares were disposed of at $7.23 per share, likely for tax withholding related to these dividend equivalents.
- Following these transactions, Nisita's direct beneficial ownership stands at 58,284.158 shares of common stock.
- The reported beneficial ownership includes an addition of 1,364.619 shares from dividend equivalents net of withholding tax not previously required to be reported.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive filing, as it confirms the achievement of performance goals leading to PSU vesting for a key executive, which is a sign of operational success. The disposals are routine tax-related transactions.
Positives
- Vesting of 16,287 performance share units (PSUs) indicates the achievement of performance goals set by Organon & Co.'s Talent Committee, reflecting successful performance.
- Acquisition of 4,596 shares from dividend equivalents demonstrates the company's dividend policy and the value accrual for shareholders and executives.
Negatives
- Disposal of 6,210 shares at $7.17 and 1,575 shares at $7.23 for tax withholding purposes reduces the executive's direct ownership, though this is a standard practice for equity compensation.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that the vesting of performance share units for an executive is a routine event in the pharmaceutical and biotechnology industry, reflecting the achievement of pre-defined corporate or individual performance metrics. Such disclosures provide transparency into executive compensation structures and insider holdings, which are closely watched by investors for insights into management's alignment with shareholder interests.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Vittorio Nisita granted a Power of Attorney to Tarnetta V. Jones and Faye C. Brown to execute SEC Forms 3, 4, and 5, and manage his EDGAR account. This streamlines compliance with Section 16(a) of the Securities Exchange Act of 1934. | 2025-07-27 | Enhances efficiency and ensures timely and accurate filing of insider transaction reports, reducing administrative burden on the executive and ensuring regulatory compliance. |
Related Party Transactions
- The acquisition of shares through performance share unit vesting and dividend equivalents, and subsequent tax-related dispositions, represent transactions between an officer (Vittorio Nisita) and the company (Organon & Co.) as part of an approved executive compensation plan.
Stakeholder Impact
- Shareholders: The vesting of PSUs indicates that performance targets were met, which could be viewed positively as it aligns executive incentives with company performance. The increase in executive ownership (net of tax) also signals confidence.
- Employees: The successful vesting of PSUs for a senior executive might serve as a positive signal regarding the company's performance and the potential for similar equity-based incentives for other employees.
Key Dates
| Date | Description |
|---|---|
| 2023-08-11 | Date performance share units (PSUs) were granted to Vittorio Nisita under the Organon & Co. 2021 Incentive Stock Plan. |
| 2025-07-27 | Date Vittorio Nisita executed the Power of Attorney for SEC filings, appointing Tarnetta V. Jones and Faye C. Brown as attorneys-in-fact. |
| 2026-02-27 | Date of reported transactions for common stock acquisition and disposition related to PSU vesting and dividend equivalents. |
| 2026-03-03 | Date the Form 4 was signed by the attorney-in-fact for Vittorio Nisita. |
Recommendation
holdThis Form 4 filing details routine executive compensation transactions, specifically the vesting of performance share units and related tax withholdings. While the vesting indicates performance goal achievement, it does not provide new material information about the company's financial health or strategic direction that would warrant a change in investment recommendation. It's an expected event for an executive's equity compensation.
Keywords
Organon & Co., OGN, Vittorio Nisita, Form 4, Insider Trading, Beneficial Ownership, Performance Share Units, PSUs, Equity Compensation, Dividend Equivalents, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.